F L Greenway

Summary

Affiliation: Pennington Biomedical Research Center
Country: USA

Publications

  1. ncbi request reprint Obesity medications and the treatment of type 2 diabetes
    F Greenway
    Pennington Biomedical Research Center, Baton Rouge, Louisiana, USA
    Diabetes Technol Ther 1:277-87. 1999
  2. ncbi request reprint Pharmaceutical cost savings of treating obesity with weight loss medications
    F L Greenway
    Pennington Biomedical Research Center, Baton Rouge, LA 70808 4124, USA
    Obes Res 7:523-31. 1999
  3. ncbi request reprint Methods to maximize retention in weight loss studies
    F L Greenway
    Pennington Biomedical Research Center, Baton Rouge, LA 70808 4124, USA
    Obes Res 7:593-6. 1999
  4. pmc Pioglitazone treatment in type 2 diabetes mellitus when combined with portion control diet modifies the metabolic syndrome
    A K Gupta
    Pennington Biomedical Research Center, Louisiana State University System, Baton Rouge, LA 70808, USA
    Diabetes Obes Metab 11:330-7. 2009
  5. ncbi request reprint Sibutramine produces dose-related weight loss
    G A Bray
    Pennington Biomedical Research Center, Baton Rouge, LA 70808, USA
    Obes Res 7:189-98. 1999
  6. ncbi request reprint Psychological and behavioral predictors of weight loss during drug treatment for obesity
    L G Womble
    Pennington Biomedical Research Center, Louisiana State University, 6400 Perkins Road, Baton Rouge, LA 70808, USA
    Int J Obes Relat Metab Disord 25:340-5. 2001
  7. ncbi request reprint The effect of an herbal dietary supplement containing ephedrine and caffeine on oxygen consumption in humans
    F L Greenway
    Pennington Biomedical Research Center, Baton Rouge, Louisiana 70808, USA
    J Altern Complement Med 6:553-5. 2000
  8. pmc Prediabetes is associated with abnormal circadian blood pressure variability
    A K Gupta
    Pennington Biomedical Research Center, Louisiana State University System, Baton Rouge, Louisiana 70808, USA
    J Hum Hypertens 22:627-33. 2008
  9. ncbi request reprint The safety and efficacy of pharmaceutical and herbal caffeine and ephedrine use as a weight loss agent
    F L Greenway
    Pennington Biomedical Research Center, 6400 Perkins Road, Baton Rouge, Louisiana 70808, USA
    Obes Rev 2:199-211. 2001
  10. pmc Subtyping obesity with microarrays: implications for the diagnosis and treatment of obesity
    S Wang
    Pennington Biomedical Research Center, Louisiana State University System, Baton Rouge, LA 70808, USA
    Int J Obes (Lond) 33:481-9. 2009

Detail Information

Publications32

  1. ncbi request reprint Obesity medications and the treatment of type 2 diabetes
    F Greenway
    Pennington Biomedical Research Center, Baton Rouge, Louisiana, USA
    Diabetes Technol Ther 1:277-87. 1999
    ..Many new medications are in development for the treatment of obesity. These new medications act through a variety of mechanisms and will surely play an increasingly important role in the treatment of obese patients with type 2 diabetes...
  2. ncbi request reprint Pharmaceutical cost savings of treating obesity with weight loss medications
    F L Greenway
    Pennington Biomedical Research Center, Baton Rouge, LA 70808 4124, USA
    Obes Res 7:523-31. 1999
    ....
  3. ncbi request reprint Methods to maximize retention in weight loss studies
    F L Greenway
    Pennington Biomedical Research Center, Baton Rouge, LA 70808 4124, USA
    Obes Res 7:593-6. 1999
    ..These three methods of retention were compared with a commercial weight loss clinic's practice of charging nonrefundable fees...
  4. pmc Pioglitazone treatment in type 2 diabetes mellitus when combined with portion control diet modifies the metabolic syndrome
    A K Gupta
    Pennington Biomedical Research Center, Louisiana State University System, Baton Rouge, LA 70808, USA
    Diabetes Obes Metab 11:330-7. 2009
    ..Treatment with thiazolidinediones (TZDs) produces weight gain...
  5. ncbi request reprint Sibutramine produces dose-related weight loss
    G A Bray
    Pennington Biomedical Research Center, Baton Rouge, LA 70808, USA
    Obes Res 7:189-98. 1999
    ..This paper reports a 24-week dose-ranging study to determine the effect of sibutramine on body weight of patients with obesity...
  6. ncbi request reprint Psychological and behavioral predictors of weight loss during drug treatment for obesity
    L G Womble
    Pennington Biomedical Research Center, Louisiana State University, 6400 Perkins Road, Baton Rouge, LA 70808, USA
    Int J Obes Relat Metab Disord 25:340-5. 2001
    ....
  7. ncbi request reprint The effect of an herbal dietary supplement containing ephedrine and caffeine on oxygen consumption in humans
    F L Greenway
    Pennington Biomedical Research Center, Baton Rouge, Louisiana 70808, USA
    J Altern Complement Med 6:553-5. 2000
    ..To determine if an herbal dietary supplement for weight loss increases metabolism...
  8. pmc Prediabetes is associated with abnormal circadian blood pressure variability
    A K Gupta
    Pennington Biomedical Research Center, Louisiana State University System, Baton Rouge, Louisiana 70808, USA
    J Hum Hypertens 22:627-33. 2008
    ..001). ACV detected with 7-day ABPM may account for the enhanced CVD risk in prediabetes. These findings provide a basis for larger-scale studies to assess the predictive value of 7-day ABPM over the long term...
  9. ncbi request reprint The safety and efficacy of pharmaceutical and herbal caffeine and ephedrine use as a weight loss agent
    F L Greenway
    Pennington Biomedical Research Center, 6400 Perkins Road, Baton Rouge, Louisiana 70808, USA
    Obes Rev 2:199-211. 2001
    ..Restriction of dietary herbal supplements containing caffeine and ephedrine, often with other ingredients, should be based on controlled clinical trials of these products...
  10. pmc Subtyping obesity with microarrays: implications for the diagnosis and treatment of obesity
    S Wang
    Pennington Biomedical Research Center, Louisiana State University System, Baton Rouge, LA 70808, USA
    Int J Obes (Lond) 33:481-9. 2009
    ..We aimed to separate obese subjects into distinct subgroups using microarray technology to identify gene expression-based subgroups to predict weight loss...
  11. ncbi request reprint Using intranasal lidocaine to reduce food intake
    F L Greenway
    Outpatient Clinic Unit, Pennington Biomedical Research Center, Louisiana State University System, Baton Rouge, LA 70808, USA
    Int J Obes (Lond) 31:858-63. 2007
    ..Develop a dose-response curve for the effect of intranasal lidocaine on food intake...
  12. ncbi request reprint Common apolipoprotein A-IV variants are associated with differences in body mass index levels and percentage body fat
    M Lefevre
    Pennington Biomedical Research Center, Baton Rouge, LA, USA
    Int J Obes Relat Metab Disord 24:945-53. 2000
    ..To determine the relationship between two common apoA-IV variants (Thr347-->Ser; Gln360-->His), and body mass index (BMI) and percentage body fat...
  13. ncbi request reprint Body image assessment for obesity (BIA-O): development of a new procedure
    D A Williamson
    Louisiana State University, Pennington Biomedical Research Center, Baton Rouge 70808, USA
    Int J Obes Relat Metab Disord 24:1326-32. 2000
    ..Separate BIA-O procedures were developed for men and women. Current, ideal and reasonable body image estimates of Caucasian and African-American men and women were compared...
  14. ncbi request reprint Double-blind, randomized, placebo-controlled clinical trials with non-prescription medications for the treatment of obesity
    F Greenway
    Pennington Biomedical Research Center, Baton Rouge, LA 70808 4124, USA
    Obes Res 7:370-8. 1999
    ..These studies explore the safety and efficacy of low-dose PPA, pseudoephedrine, and PPA with benzocaine in causing weight loss...
  15. ncbi request reprint Serial echocardiographic and clinical evaluation of valvular regurgitation before, during, and after treatment with fenfluramine or dexfenfluramine and mazindol or phentermine
    D H Ryan
    Pennington Biomedical Research Center, Baton Rouge, LA 70808 4124, USA
    Obes Res 7:313-22. 1999
    ..We studied 86 patients who had echocardiograms before treatment with appetite suppressants to determine the incidence of new cases and to evaluate the clinical implication of the echocardiographic findings...
  16. pmc Effect of diet composition on energy expenditure during weight loss: the POUNDS LOST Study
    G A Bray
    Pennington Biomedical Research Center, Baton Rouge, LA 70808, USA
    Int J Obes (Lond) 36:448-55. 2012
    ..Hypothesis: We tested the hypothesis that macronutrient composition of the diet might affect the partitioning of energy expenditure during weight loss...
  17. pmc Effect of valproic acid on body weight, food intake, physical activity and hormones: results of a randomized controlled trial
    C K Martin
    Pennington Biomedical Research Center, Baton Rouge, Louisiana, USA
    J Psychopharmacol 23:814-25. 2009
    ..Research testing VPA on short-term (1 week) EI, metabolism, and substrate partitioning is warranted...
  18. doi request reprint Lifestyle factors and ghrelin: critical review and implications for weight loss maintenance
    C E Adams
    Department of Psychology, Louisiana State University Pennington Biomedical Research Center, Baton Rouge, LA, USA
    Obes Rev 12:e211-8. 2011
    ..Future directions for investigating relationships between ghrelin and behavioural factors, examining the efficacy of behavioural programmes in reducing ghrelin and improving weight loss maintenance are discussed...
  19. ncbi request reprint The future of obesity research
    F L Greenway
    Outpatient Clinic, Pennington Biomedical Research Center, Baton Rouge, Louisiana, USA
    Nutrition 16:976-82. 2000
    ..Due to the availability of molecular approaches, obesity treatment is expected to advance faster than chronic disease research of the past...
  20. ncbi request reprint Safety and efficacy of NT, an herbal supplement, in treating human obesity
    F L Greenway
    Pennington Biomedical Research Center, Clinical Trials Department, Louisiana State University System, Baton Rouge, LA 70808 4124, USA
    Int J Obes (Lond) 30:1737-41. 2006
    ..A human pilot study testing the safety and effectiveness of NT (Number Ten), a dietary herbal supplement made from rhubarb, ginger, astragulus, red sage and turmeric, to reduce food intake and cause weight loss...
  21. doi request reprint Combination therapy with naltrexone and bupropion for obesity reduces total and visceral adiposity
    S R Smith
    Translational Research Institute for Metabolism and Diabetes, Florida Hospital Burnham Institute, Winter Park, FL 32789, USA
    Diabetes Obes Metab 15:863-6. 2013
    ..Reductions in body fat and VAT mass with naltrexone/bupropion were proportional with weight loss. Weight loss with naltrexone/bupropion was not associated with a greater relative reduction in lean mass than placebo or the monotherapies. ..
  22. doi request reprint Caenorhabditis elegans as a model for obesity research
    J Zheng
    Louisiana State University Agricultural Center, Department of Veterinary Science, Baton Rouge, Louisiana 70808, USA
    Int J Obes (Lond) 36:186-94. 2012
    ..We present this review hoping to stimulate interest in using the C. elegans model as a vehicle to advance the understanding and future treatment of obesity...
  23. ncbi request reprint Topical fat reduction from the waist
    M K Caruso
    Louisiana State University Division of Human Ecology, Baton Rouge, LA, USA
    Diabetes Obes Metab 9:300-3. 2007
    ..This study is designed to test the hypothesis that aminophylline cream application to the waist will reduce waist circumference compared with a control...
  24. pmc Association of β-2 adrenergic agonist and corticosteroid injection in the treatment of lipomas
    L M Redman
    John S McIlhenny Skeletal Muscle, Pennington Biomedical Research Center, Louisiana State University System, Baton Rouge, LA, USA
    Diabetes Obes Metab 13:517-22. 2011
    ..The aim of this study was to evaluate the efficacy of isoproterenol and prednisolone in the treatment of subcutaneous lipomas...
  25. pmc Template to improve glycemic control without reducing adiposity or dietary fat
    R Krishnapuram
    Infections and Obesity Laboratory, Pennington Biomedical Research Center, Louisiana State Univ System, 6400 Perkins Rd, Baton Rouge, LA 70808, USA
    Am J Physiol Endocrinol Metab 300:E779-89. 2011
    ..This metabolic engineering by Ad36 appears relevant to humans for developing more practical and effective antidiabetic approaches...
  26. ncbi request reprint Body Morph Assessment: preliminary report on the development of a computerized measure of body image
    T M Stewart
    Pennington Biomedical Research Center, Louisiana State University, Baton Rouge, 70808, USA
    Obes Res 9:43-50. 2001
    ..DISCUSSION: These preliminary findings support the reliability and validity of the BMA with white women. Given these positive findings, we plan to extend the procedure to males and to other racial and ethnic groups...
  27. ncbi request reprint Evaluating commercial weight loss programmes: an evolution in outcomes research
    M Hamilton
    Pennington Biomedical Research Center, Baton Rouge, LA 70808, USA
    Obes Rev 5:217-32. 2004
    ....
  28. ncbi request reprint Contributions of total body fat, abdominal subcutaneous adipose tissue compartments, and visceral adipose tissue to the metabolic complications of obesity
    S R Smith
    Pennington Biomedical Research Center, Baton Rouge, LA 70808, USA
    Metabolism 50:425-35. 2001
    ..375). These data suggest that total body fat is a major contributor to the metabolic sequelae of obesity, with specific fat depots, VAT, and DSAT also making significant contributions...
  29. ncbi request reprint A rare mutation in AgRP, +79G>A, affects promoter activity
    M A Sözen
    Pennington Biomedical Research Center, Louisiana State University System, Baton Rouge, LA, USA
    Eur J Clin Nutr 61:809-12. 2007
    ....
  30. ncbi request reprint Stimulation of cholecystokinin-A receptors with GI181771X does not cause weight loss in overweight or obese patients
    J Jordan
    Franz Volhard Clinical Research Center, Helios Klinikum and Medical Faculty of the Charité, Berlin, Germany
    Clin Pharmacol Ther 83:281-7. 2008
    ..Gastrointestinal side effects were more common with GI181771X than with placebo treatment, whereas hepatobiliary or pancreatic abnormalities did not occur. CCK-A by itself does not have a central role in long-term energy balance...
  31. ncbi request reprint Psychosocial variables associated with binge eating in obese males and females
    L G Womble
    Department of Psychiatry, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, USA
    Int J Eat Disord 30:217-21. 2001
    ..Longitudinal studies, however, are needed to examine these etiological paths and to test for causal relationships...
  32. ncbi request reprint Retention rates and weight loss in a commercial weight loss program
    C E Finley
    The Cooper Institute, Center for Epidemiologic Research, Dallas, TX, USA
    Int J Obes (Lond) 31:292-8. 2007
    ..To evaluate and describe retention rates and weight loss in clients participating in a commercial weight loss program...